PMV Pharmaceuticals, Inc. (PMVP)

1.8600 +0.0600 (+3.33%) 收市：04:00PM EDT

PMV Pharmaceuticals, Inc.

1 Research Way
Princeton, NJ 08540
United States
609 642 6670
https://www.pmvpharma.com

版塊: Healthcare
行業: Biotechnology
全職員工: 63

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. David H. Mack Ph.D.	Co-Founder, CEO, President & Director	881.08k	無	1962
Dr. Arnold J. Levine Ph.D.	Co-Founder, Director & Member of Scientific Advisory Board	140k	無	1940
Dr. Deepika Jalota Pharm.D.	Chief Development Officer	593.9k	無	1977
Dr. Thomas E. Shenk Ph.D.	Co-Founder & Member of Scientific Advisory Board	無	無	1947
Mr. Michael Carulli	Chief Financial Officer	無	無	1974
Mr. Robert Ticktin	General Counsel, Head of Operations & Company Secretary	無	無	1962
Mr. Tim Smith	Senior VP & Head of Corporate Development and Investor Relations	無	無	無
Ms. Crystal Zuckerman	Vice President of Human Resources	無	無	無
Dr. Binh Vu Ph.D.	Senior VP of Drug Discovery & CMC	無	無	無
Dr. Marc Fellous M.D.	Senior VP and Head of Clinical Development & Medical Affairs	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

公司管治

截至 2024年4月29日 止，PMV Pharmaceuticals, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：5；董事會：6；股東權利：7；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。